Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorZhang, Le
dc.contributor.authorYao, Honghui
dc.contributor.authorJendle, Johan
dc.contributor.authorRibases Haro, Marta
dc.contributor.authorGarcia-Argibay, Miguel
dc.contributor.authorLi, Lin
dc.contributor.authorDu Rietz, Ebba
dc.contributor.authorRamos-Quiroga, Josep Antoni
dc.date.accessioned2023-02-23T13:08:12Z
dc.date.available2023-02-23T13:08:12Z
dc.date.issued2023-04
dc.identifier.citationGarcia-Argibay M, Li L, Du Rietz E, Zhang L, Yao H, Jendle J, et al. The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study. Neurosci Biobehav Rev. 2023 Apr;147:105076.
dc.identifier.issn0149-7634
dc.identifier.urihttps://hdl.handle.net/11351/9044
dc.descriptionAttention deficit hyperactivity disorder; Cardiovascular risk factors; Type 2 diabetes
dc.description.abstractWe conducted a systematic review and a meta-analysis to quantitatively summarize evidence on the association between attention-deficit/hyperactivity disorder (ADHD) and type 2 diabetes (T2D). Moreover, a register-based sibling study was conducted to simultaneously control for confounding factors. A systematic search identified four eligible observational studies (N = 5738,287). The meta-analysis showed that individuals with ADHD have a more than doubled risk of T2D when considering adjusted estimates (OR=2.29 [1.48–3.55], d=0.46). Results from the register-based Swedish data showed a significant association between ADHD and T2D (HR=2.35 [2.14–2.58]), with substance use disorder, depression, and anxiety being the main drivers of the association, and cardiovascular and familiar risk playing a smaller role. While results from the meta-analysis provide evidence for an increased risk of T2D in individuals with ADHD, the register-based analyses show that the association between ADHD and T2D is largely explained by psychiatric comorbidities. Pending further evidence of causal association, our findings suggest that early identification and treatment of ADHD comorbidities might greatly reduce the risk of developing T2D in individuals with ADHD.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesNeuroscience & Biobehavioral Reviews;147
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMalalties - Factors de risc
dc.subjectDiabetis no-insulinodependent - Epidemiologia
dc.subjectTrastorn per dèficit d'atenció amb hiperactivitat - Epidemiologia
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshAttention Deficit Disorder with Hyperactivity
dc.subject.meshRisk Factors
dc.subject.mesh/epidemiology
dc.titleThe association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.neubiorev.2023.105076
dc.subject.decsdiabetes mellitus tipo II
dc.subject.decstrastornos de déficit de atención con hiperactividad
dc.subject.decsfactores de riesgo
dc.subject.decs/epidemiología
dc.relation.publishversionhttps://doi.org/10.1016/j.neubiorev.2023.105076
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Garcia-Argibay M, Li L] School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [Du Rietz E, Zhang L, Yao H] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [Jendle J] School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden. [Ramos-Quiroga JA] Departament de Psiquiatria i Medicina Forense, Universitat Autònoma de Barcelona, Bellaterra, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain. Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Unitat de Genètica Psiquiàtrica, Grup de Recerca de Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ribasés M] Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain. Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Unitat de Genètica Psiquiàtrica, Grup de Recerca de Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid36754221
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/H2020/965381
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record